Pharmacogenomic Study of Clozapine-Induced Agranulocytosis/Granulocytopenia in a Japanese Population
暂无分享,去创建一个
Shuji Hashimoto | Takeshi Ozeki | Kiyotaka Nemoto | Masatoshi Takeda | Kohei Kawase | Yoichiro Kamatani | Michiaki Kubo | Tetsuro Noda | Masaharu Kubota | Shu-ichi Ueno | Atsushi Takahashi | Tetsuro Ohmori | Yuji Yada | Masaru Murakami | Hidenaga Yamamori | Yuka Yasuda | Michiko Fujimoto | Ryota Hashimoto | Y. Kamatani | N. Kanahara | T. Mushiroda | M. Kubo | A. Takahashi | M. Ikeda | K. Ohi | R. Hashimoto | M. Takeda | H. Yamamori | K. Nemoto | T. Ohmori | N. Iwata | Y. Yasuda | M. Makinodan | S. Hashimoto | M. Fujimoto | S. Ueno | S. Numata | A. Shimasaki | T. Ozeki | Nakao Iwata | Manabu Takaki | Taisei Mushiroda | Manabu Makinodan | Takuya Fukao | Kazutaka Ohi | M. Kubota | Takemi Kimura | Masashi Ikeda | Takemi Kimura | M. Takaki | K. Fujita | Y. Nishihata | Shusuke Numata | Nobuhisa Kanahara | Takeo Saito | Kenji Kondo | Ayu Shimasaki | Yosuke Nishihata | Naoki Hashimoto | Kiyoshi Fujita | Taku Fukao | Taro Suwa | Naoya Kida | Taku Otsuru | Takeo Saito | Taro Suwa | Yuji Yada | T. Noda | Naoki Hashimoto | Naoya Kida | M. Murakami | Kenji Kondo | Kohei Kawase | Taku Otsuru | Ayu Shimasaki | M. Kubo | Shusuke Numata
[1] G. Johnson,et al. Clozapine treatment in Australia: a review of haematological monitoring , 1998, The Medical journal of Australia.
[2] J. Lieberman,et al. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. , 1993, The New England journal of medicine.
[3] Genome-wide environment interaction between depressive state and stressful life events. , 2016, The Journal of clinical psychiatry.
[4] Yusuke Nakamura,et al. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. , 2008, American journal of human genetics.
[5] R. Kerwin,et al. Active monitoring of 12760 clozapine recipients in the UK and Ireland , 1999, British Journal of Psychiatry.
[6] S. Leucht,et al. Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective , 2014, Evidence-Based Mental Health.
[7] K. Wahlbeck,et al. Clozapine versus typical neuroleptic medication for schizophrenia. , 2000, The Cochrane database of systematic reviews.
[8] D. Reich,et al. Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.
[9] F. Carvalho,et al. Haematological toxicity of clozapine and some other drugs used in psychiatry , 2011, Human psychopharmacology.
[10] A. Malhotra,et al. Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis. , 2011, The Journal of clinical psychiatry.
[11] A. Lang,et al. Response to clozapine in a clinically identifiable subtype of schizophrenia. , 2015, The British journal of psychiatry : the journal of mental science.
[12] H. Möller,et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[13] L. Graaf. Clozapine , 1989, The Lancet.
[14] M. Daly,et al. Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles , 2014, Nature Communications.
[15] A. Malhotra,et al. Pharmacogenetics of antipsychotics: recent progress and methodological issues , 2013, Expert opinion on drug metabolism & toxicology.
[16] M. Lambert,et al. Randomized double blind comparison of olanzapine vs. clozapine on subjective well‐being and clinical outcome in patients with schizophrenia , 2005, Acta psychiatrica Scandinavica.
[17] Carson C Chow,et al. Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.
[18] Michael Boehnke,et al. LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..
[19] B. Bain,et al. Exercise induced mobilisation of the marginated granulocyte pool in the investigation of ethnic neutropenia , 2000, Journal of clinical pathology.
[20] Peter B. Jones,et al. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. , 2005, Schizophrenia bulletin.
[21] H. Freeman,et al. Neutropenia and Agranulocytosis in Patients Receiving Clozapine in the UK and Ireland , 1996, British Journal of Psychiatry.
[22] C. Andrews,et al. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy , 2006, British Journal of Psychiatry.
[23] Dan Cohen,et al. Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy. , 2012, The Journal of clinical psychiatry.
[24] W. Fleischhacker,et al. Clozapine-induced transient white blood count disorders. , 1994, The Journal of clinical psychiatry.